Evidence map›Paper›PMID 40185804›Full record

ArticleScientific reports2025

Associations of fluctuations in blood glucose and insulin with hypoglycemic symptoms.

Toru Mizoguchi, Naoki Aoyama, Yoh Jinnouchi, Mikiko Inoue, Eri Eguchi, Tetsuya Ohira

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Anaglycemia and Cataglycemia: Proposed Terminology for Glucose Dynamics.Journal of diabetes science and technology · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Toru MizoguchiMizoguchi Clinic, Yaesu Nakadori Bldg. 11F, 1-4-10 Yaesu, Chuo-ku, Tokyo, 103-0028, Japan. mizo@mizoclinic.tokyo.
Naoki AoyamaNakameguro Neuro Care and Headache Clinic, WIND NAKAMEGURO BLDG.3F, 3-6-18 Kamimeguro, Meguro-ku, Tokyo, 153-0051, Japan.
Yoh JinnouchiMizoguchi Clinic, Yaesu Nakadori Bldg. 11F, 1-4-10 Yaesu, Chuo-ku, Tokyo, 103-0028, Japan.
Mikiko InoueMizoguchi Clinic, Yaesu Nakadori Bldg. 11F, 1-4-10 Yaesu, Chuo-ku, Tokyo, 103-0028, Japan.
Eri EguchiDepartment of Epidemiology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-8061, Japan.
Tetsuya OhiraDepartment of Epidemiology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-8061, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Associations between fluctuations in blood glucose levels and medically unexplained symptoms, such as palpitations, numbness in the extremities, dizziness, and drowsiness, have been a topic of debate for an extended period; however, consensus remains elusive. We therefore examined the associations of blood glucose and insulin levels with symptoms by performing a 5 h glucose tolerance test in patients without diabetes with complaints. A total of 139 (54 men and 85 women, mean age 35.4 years) were included in this study. Blood glucose and insulin levels were measured before and at 15, 30, 60, 90, 120, 150, 180, 240, and 300 min after a 10-h fast and 75 g glucose load. The insulin index was used to divide the participants into early, intermediate, and delayed insulin secretion groups. Hypoglycemic symptoms (neuroglycopenic: warmth, drowsiness, weakness, fainting, decreased thinking ability, and dizziness) and autonomic symptoms (neurogenic: palpitations, cold sweats, anxiety/nervousness, tremors, hunger, and tingling) were evaluated separately. Hypoglycemia (< 70 mg/dL (3.9 mmol/L)) occurred at 240-300 min in 92% of all patients, with hypoglycemic and autonomic symptoms. Hypoglycemic symptoms increased over time and were highest at 240 min, while autonomic symptoms decreased significantly for 15 min and increased at 240 and 300 min. Although hypoglycemic symptoms were not significantly different among the early, intermediate, and delayed secretion groups, the incidence rates of autonomic symptoms were higher in the early insulin secretion group than in the other groups at 30-60-90 min. The characteristics of the early insulin secretion group suggested that symptoms were associated with not only blood glucose levels but also the timing of insulin secretion. Further studies are needed to determine whether dietary interventions tailored to insulin secretion profiles can alleviate these symptoms.

Indexed as

Blood GlucoseHypoglycemiaInsulinAdultFemaleGlucose Tolerance TestHumansMaleMiddle AgedBlood GlucoseInsulinAutonomic symptomsGlucose tolerance testHyperinsulinismHypoglycemiaMental symptoms

Identifiers

PMID40185804
PMCPMC11971238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.